Vaccines A-Z

Precision Vaccinations

 / April 16th, 2024

Eliminating fake vaccine news with pharmacist, nurse, and physician review.

Apr 16 • 10:50 am CDT
The U.S. FDA has set February 14, 2025, as the action date for a GSK MenABCWY combination vaccine candidate that protects against the five most common groups of bacteria causing invasive meningococcal disease. GSK’s 5-in-1 MenABCWY... READ →
Apr 16 • 9:34 am CDT
A global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”) announced today a co-development and licensing agreement with The University of Texas MD Anderson Cancer Center to develop novel... READ →
Apr 16 • 8:24 am CDT
A newly approved vaccine option for protecting adults from hepatitis B (HepB) reported positive news. Today, VBI Vaccines Inc. provided a business update that included the PreHevbrio™ (PreHevbri®, Sci-B-Vac®) vaccine and announced financial results for the... READ →
Apr 15 • 3:13 pm CDT
Despite the expenditure of over $3 billion to fight malaria outbreaks since 2021, the world still witnessed an estimated 600,000 malaria deaths and 247 million clinical malaria cases. To address malaria outbreaks in Africa, new v... READ →
Apr 15 • 8:50 am CDT
Soligenix, Inc. announced today that the Office of Orphan Products Development of the United States Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient in MarVax™, the subunit protein vaccine of... READ →

For more articles, try our search.